Cargando…

The Regulatory Environment of Telemedicine After COVID-19

The COVID-19 pandemic has created many barriers to providing health care, yet it also has created new opportunities. Although telemedicine was a nascent means of health care delivery before COVID-19, it now is one of the principal means for doing so today, and it is likely to remain so. Whether this...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandya, Aarti, Waller, Morgan, Portnoy, Jay M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277986/
https://www.ncbi.nlm.nih.gov/pubmed/35842133
http://dx.doi.org/10.1016/j.jaip.2022.07.001
_version_ 1784746103140253696
author Pandya, Aarti
Waller, Morgan
Portnoy, Jay M.
author_facet Pandya, Aarti
Waller, Morgan
Portnoy, Jay M.
author_sort Pandya, Aarti
collection PubMed
description The COVID-19 pandemic has created many barriers to providing health care, yet it also has created new opportunities. Although telemedicine was a nascent means of health care delivery before COVID-19, it now is one of the principal means for doing so today, and it is likely to remain so. Whether this will happen may depend in part on continued relaxation of regulations that hampered it before the pandemic. Whereas enforcement of compliance with Health Information Portability and Accountability Act will most likely resume, platform operators and providers have had an opportunity to prepare for this. State licensure requirements may also resume; however, the regulations were in the process of becoming more liberal before COVID-19 so that process might continue. There is no reason to anticipate that payment for telemedicine services including check-ins, remote physiologic and therapeutic monitoring, and relaxation of location and service requirements will end. For these reasons, telemedicine therefore is likely to continue as an important part of medical practice.
format Online
Article
Text
id pubmed-9277986
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Academy of Allergy, Asthma & Immunology
record_format MEDLINE/PubMed
spelling pubmed-92779862022-07-14 The Regulatory Environment of Telemedicine After COVID-19 Pandya, Aarti Waller, Morgan Portnoy, Jay M. J Allergy Clin Immunol Pract Review and Feature Article The COVID-19 pandemic has created many barriers to providing health care, yet it also has created new opportunities. Although telemedicine was a nascent means of health care delivery before COVID-19, it now is one of the principal means for doing so today, and it is likely to remain so. Whether this will happen may depend in part on continued relaxation of regulations that hampered it before the pandemic. Whereas enforcement of compliance with Health Information Portability and Accountability Act will most likely resume, platform operators and providers have had an opportunity to prepare for this. State licensure requirements may also resume; however, the regulations were in the process of becoming more liberal before COVID-19 so that process might continue. There is no reason to anticipate that payment for telemedicine services including check-ins, remote physiologic and therapeutic monitoring, and relaxation of location and service requirements will end. For these reasons, telemedicine therefore is likely to continue as an important part of medical practice. American Academy of Allergy, Asthma & Immunology 2022-10 2022-07-13 /pmc/articles/PMC9277986/ /pubmed/35842133 http://dx.doi.org/10.1016/j.jaip.2022.07.001 Text en © 2022 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review and Feature Article
Pandya, Aarti
Waller, Morgan
Portnoy, Jay M.
The Regulatory Environment of Telemedicine After COVID-19
title The Regulatory Environment of Telemedicine After COVID-19
title_full The Regulatory Environment of Telemedicine After COVID-19
title_fullStr The Regulatory Environment of Telemedicine After COVID-19
title_full_unstemmed The Regulatory Environment of Telemedicine After COVID-19
title_short The Regulatory Environment of Telemedicine After COVID-19
title_sort regulatory environment of telemedicine after covid-19
topic Review and Feature Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277986/
https://www.ncbi.nlm.nih.gov/pubmed/35842133
http://dx.doi.org/10.1016/j.jaip.2022.07.001
work_keys_str_mv AT pandyaaarti theregulatoryenvironmentoftelemedicineaftercovid19
AT wallermorgan theregulatoryenvironmentoftelemedicineaftercovid19
AT portnoyjaym theregulatoryenvironmentoftelemedicineaftercovid19
AT pandyaaarti regulatoryenvironmentoftelemedicineaftercovid19
AT wallermorgan regulatoryenvironmentoftelemedicineaftercovid19
AT portnoyjaym regulatoryenvironmentoftelemedicineaftercovid19